MXPA03002864A - Portafolios de pronostico de cancer de mama. - Google Patents

Portafolios de pronostico de cancer de mama.

Info

Publication number
MXPA03002864A
MXPA03002864A MXPA03002864A MXPA03002864A MXPA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A
Authority
MX
Mexico
Prior art keywords
breast cancer
genes
cancer prognostic
prognostic portfolio
portfolio
Prior art date
Application number
MXPA03002864A
Other languages
English (en)
Spanish (es)
Inventor
Yixin Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29215884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03002864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03002864A publication Critical patent/MXPA03002864A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
MXPA03002864A 2002-03-29 2003-03-31 Portafolios de pronostico de cancer de mama. MXPA03002864A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36878902P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
MXPA03002864A true MXPA03002864A (es) 2004-08-11

Family

ID=29215884

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002864A MXPA03002864A (es) 2002-03-29 2003-03-31 Portafolios de pronostico de cancer de mama.

Country Status (11)

Country Link
US (1) US7473526B2 (enExample)
EP (1) EP1367138B1 (enExample)
JP (1) JP2003325192A (enExample)
KR (1) KR20030078805A (enExample)
CN (1) CN1495274A (enExample)
AR (1) AR039213A1 (enExample)
AU (1) AU2003203557B2 (enExample)
BR (1) BR0303092A (enExample)
CA (1) CA2422303A1 (enExample)
DE (1) DE60317606T2 (enExample)
MX (1) MXPA03002864A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361433A3 (en) * 2002-04-09 2005-02-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
US20050003422A1 (en) * 2003-07-01 2005-01-06 Mitch Reponi Methods for assessing and treating cancer
JP5089993B2 (ja) * 2004-02-20 2012-12-05 ベリデックス・エルエルシー 乳癌の予後診断
JP2007532142A (ja) * 2004-04-23 2007-11-15 エグザジェン ダイアグノスティクス インコーポレイテッド 乳がん遺伝子発現バイオマーカー
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
EP2380978A3 (en) * 2006-02-03 2012-02-29 MessengerScape Co. Ltd. Gene group applicable to cancer prognostication
BRPI0720219A2 (pt) 2006-12-08 2013-12-24 Univ Iowa State Res Found Inc Genes de planta envolvidos em absorção e metabolismo de nitrato
CN105224827B (zh) * 2008-07-01 2019-12-24 小利兰·斯坦福大学托管委员会 用于发展ivf治疗协议的分析数据的计算机系统和存储介质
ES2338843B1 (es) * 2008-07-02 2011-01-24 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Huella genomica de cancer de mama.
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
US10011876B2 (en) 2010-11-23 2018-07-03 Krisani Biosciences Pvt. Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
KR101287600B1 (ko) * 2011-01-04 2013-07-18 주식회사 젠큐릭스 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US635152A (en) * 1899-06-05 1899-10-17 Melancthon S Shotwell Car-body bolster.
US6350576B1 (en) 1994-12-20 2002-02-26 Cold Spring Harbor Laboratory Cancer detection probes
AU5310296A (en) 1995-03-17 1996-10-08 John Wayne Cancer Institute Detection of melanoma or breast metastases with a multiple marker assay
US6275814B1 (en) 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
US6037129A (en) 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6175624B1 (en) * 1999-03-05 2001-01-16 Centurion International, Inc. Method for connecting a battery circuit in a cellular telephone
MXPA01009369A (es) 1999-03-15 2003-06-06 Eos Biotechnology Inc Nuevos metodos para el diagnostico del cancer colorectal, composiciones, y metodos para seleccionar moduladores del cancer colorectal.
JP2004507202A (ja) * 1999-03-31 2004-03-11 キュラジェン　コーポレイション ポリペプチドをコードするオープンリーディングフレームを含む核酸；「ｏｒｆｘ」
US6175824B1 (en) 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators
RU2251838C2 (ru) 1999-07-15 2005-05-20 Рисерч Дивелопмент Фаундейшн Способ получения неприродной трансгенной мыши с дефицитом гена рецептора 2 кортиколиберина и ее использование
WO2003070889A2 (en) * 2002-02-19 2003-08-28 Idec Pharmaceuticals Corporation Prostate specific genes and the use thereof in design or therapeutics
US20050054826A1 (en) * 2003-05-19 2005-03-10 Rosetta Inpharmatics Llc Human diaphanous-3 gene and methods of use therefor

Also Published As

Publication number Publication date
CA2422303A1 (en) 2003-09-29
AU2003203557B2 (en) 2007-05-24
DE60317606D1 (de) 2008-01-03
BR0303092A (pt) 2004-09-08
KR20030078805A (ko) 2003-10-08
EP1367138A2 (en) 2003-12-03
US20030190656A1 (en) 2003-10-09
US7473526B2 (en) 2009-01-06
JP2003325192A (ja) 2003-11-18
AU2003203557A1 (en) 2003-10-23
DE60317606T2 (de) 2008-10-23
AR039213A1 (es) 2005-02-09
EP1367138A3 (en) 2004-03-10
CN1495274A (zh) 2004-05-12
EP1367138B1 (en) 2007-11-21

Similar Documents

Publication Publication Date Title
MXPA03002862A (es) Panel de diagnostico del cancer.
MXPA03002864A (es) Portafolios de pronostico de cancer de mama.
WO2004065583A3 (en) Gene expression markers for breast cancer prognosis
WO2005100606A3 (en) Gene expression markers for predicting response to chemotherapy
WO2001094629A8 (en) Cancer gene determination and therapeutic screening using signature gene sets
AU2014899A (en) Metastatic breast and colon cancer regulated genes
WO2003021227A3 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
EP1492440B8 (en) A new method for the diagnosis and prognosis of malignant diseases
EP1526186A3 (en) Colorectal cancer prognostics
MXPA04003931A (es) Pronostico de cancer de mama.
EP2333112A3 (en) Breast cancer prognostics
WO2004101764A3 (en) Methods of modulating metastasis and skeletal related events resulting from metastases
WO2004005883A3 (en) Secreted and cytoplasmic tumor endothelial markers
MXPA05004971A (es) Pronostico para malignidad hematologica.
DK1058739T3 (da) Fremgangsmåde til dannelse af genekspressionsprofiler
MXPA03002863A (es) Valoracion de cancer colorrectal.
WO2004090547A3 (en) Metastatic colorectal cancer signatures
MXPA03002866A (es) Valoracion de cancer colorrectal.
WO2005002414A3 (en) Prognosis determination in ewing sarcoma patients by means of genetic profiling
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
IL126257A0 (en) Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer metastasis formation
EP1460898A4 (en) OLIGONUCLEOTIDES ANTISENSE WT1 INHIBITING BREAST CANCER
BR0012301A (pt) Inibidores de crescimento de células epiteliais
DE69733491D1 (de) In Krebszellen überexprimiertes Genprodukt
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal